IGF-1 LR3 is a synthetic long-acting analog of insulin-like growth factor-1 referenced in preclinical research literature for its defined structural modifications and receptor interaction profile. It is engineered with sequence substitutions and an N-terminal extension designed to enhance stability and is supplied for controlled laboratory investigation.
| Compound Name | IGF-1 LR3 1mg |
| CAS Number | 946870-92-4 |
| Formula | C₄₀₀H₆₂₅N₁₁₁O₁₁₅S₇ |
| Mol. Weight | 9113.45 g/mol |
| Structure | Synthetic IGF-1 Analog (83 Amino Acids; Long-Acting Variant) |
| Purity | ≥99% (HPLC Verified) |
Synthetic IGF-1 LR3 with N-terminal 13-amino acid extension and Arg³ substitution enhancing stability · Verified sequence confirmed by mass spectrometry · Each batch tested to ≥99% purity by HPLC
| Property | Value |
|---|---|
| Compound Name | IGF-1 LR3 1mg |
| Synonyms | IGF-1 LR3; Long-R3 IGF-1; Insulin-Like Growth Factor-1 Long Arg3 |
| CAS Number | 946870-92-4 |
| Molecular Formula | C₄₀₀H₆₂₅N₁₁₁O₁₁₅S₇ |
| Molecular Weight | 9113.45 g/mol |
| Structure Type | Synthetic IGF-1 Analog (83 Amino Acids; Long-Acting Variant) |
| Amino Acid Sequence | 83 |
| Purity | ≥99% (HPLC Verified) |
| Form | Lyophilized Powder |
| Quantity | 1 mg per vial |
| Appearance | White to off-white lyophilized powder |
| Solubility | Soluble in water |
| Storage | -20°C, desiccated, protect from light |
| Shelf Life | 24 months |
| Country of Origin | United States |
| Intended Use | Research purposes only |
| Attribute | Details |
|---|---|
| SKU | CBL-IGF1LR3-1 |
| Category | Peptides |
| Documentation | Batch-specific COA available on request |
| Testing Method | HPLC with UV detection; MS confirmation available |
| Regulatory Status | Research Use Only. Not for human or veterinary administration. |
Your cart is empty